Cellular Origins and Fresenius Kabi have completed the first phase of a CGT manufacturing collaboration announced in October 2024.
Cellular Origins, a TTP company, acquired the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge while CEO of SOTIO Biotech US. The ACTIA Platform complements ...
Cellular manufacturing systems (CMS) represent a pivotal approach to modern industrial production, in which machines and workstations are organised into discrete cells dedicated to the manufacture of ...
NEW YORK, May 13, 2025 /PRNewswire/ -- Global technology intelligence firm ABI Research recently completed its 2025 Manufacturers' Technology Adoption & Attitudes Survey, a comprehensive survey of 458 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results